Alpha-Specific Safety
Radiation safety for alpha emitters
Alpha particles themselves are stopped by skin, paper, or a few centimeters of air. The radiation safety challenge for Ac-225 is not external penetrating dose — it is contamination control, daughter-isotope monitoring, and the small but real penetrating dose from the decay chain. A program that copy-pastes its existing RLT safety plan onto Ac-225 will miss the things that actually matter.
Minimum requirements
An Ac-225 radiation protection program rests on three pillars:
Contamination control
- Alpha-capable survey instruments (ZnS scintillation) for surfaces and wipes
- Strict glove, gown, and dedicated-tool discipline in the hot lab and administration room
- Spill protocols addressing aerosolization and ingestion pathways
Daughter-isotope awareness
- Plan for Fr-221, Bi-213, and downstream emitters in shielding and waste
- Recognize that gamma surveys detect daughters — not the parent alphas
- Account for the full decay chain in decay-in-storage hold times
Personnel monitoring
- Bioassay program (typically urine) for staff handling open Ac-225
- Whole-body and extremity dosimetry placement reviewed by the AMP
- Incident reporting that includes contamination events, not just dose events
Carries over from RLT
- 10 CFR Part 35 Subpart E framework — written directive, AU oversight, recordkeeping
- ALARA program, dosimetry, and Radiation Safety Committee governance
- Patient-release framework under 10 CFR §35.75 (dose-rate / TEDE basis)
- Hot-lab workflow, dose calibrator QC, and survey-of-package-receipt routines
New for alpha
- Surveys must be alpha-capable — Geiger-Mueller pancakes do NOT see Ac-225 alphas
- Shielding is sized for Bi-213's 440 keV gamma, not parent alphas
- Bioassay (urine) becomes a routine, not exceptional, part of personnel monitoring
- Decay-in-storage timelines are governed by the full chain, not the 9.9-day parent
- Spill response must address inhalation and ingestion as primary intake pathways
Tip
A common pattern on new alpha programs is over-investing in lead shielding and under-investing in surface contamination controls. Internal dose from a single inhalation or ingestion event can outweigh the external dose from an entire run.
References
- 10 CFR Part 20 — Standards for Protection Against Radiation.
- 10 CFR Part 35 — Medical Use of Byproduct Material.
- NCRP Report No. 161 — Management of Persons Contaminated with Radionuclides.